National Programme FOR TB Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: National Programme FOR TB Pharmaceutical Import Records from India — 3 Products, $450.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

National Programme FOR TB — Pharmaceutical Importer Profile (2026) | 3 Products, $450.0K Trade | TransData Nexus

National Programme FOR TB

Pharmaceutical Importer · Sri Lanka · Tuberculosis Medications Focus · $450.0K Total Trade · DGFT Verified

National Programme FOR TB is a pharmaceutical importer based in Sri Lanka with a total trade value of $450.0K across 3 products in 2 therapeutic categories. Based on 9 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. National Programme FOR TB sources from 1 verified Indian supplier, with Macleods Pharmaceuticals Limited accounting for 100.0% of imports.

National Programme FOR TB — Import Portfolio & Supplier Network

National Programme FOR TB import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to National Programme FOR TB?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$250.0K	5	100.0%

National Programme FOR TB sources from 1 verified Indian supplier across 5 distinct formulations. The sourcing is highly concentrated — Macleods Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Rifampicin 150 MG / isoniazid 75 MG / ethambutol hydrochloride 275 MG tablets. (24x28's) (429 Pack)	$50.0K	1
Rifampicin capsules BP 150MG. (10x10's)(3887 Pack)	$50.0K	1
Ethambutol hydrochloride 100MG tablets.(10x10's) (1461 Pack)	$50.0K	1
Rifampicin 75MG / isoniazid 50MG / pyrazinamide 150MG disp tablets. (3x28's) (581 Pack)	$50.0K	1
Rifampicin 75MG /isoniazid 50MG dispersible tablets. (3x28's) (1371 Pack)	$50.0K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rifampicin	Advanced Antibiotics	$200.0K	4	0.0%	6
2	Isoniazid	Tuberculosis Medications	$150.0K	3	0.0%	9
3	Ethambutol	Tuberculosis Medications	$100.0K	2	0.0%	5

National Programme FOR TB imports 3 pharmaceutical products across 2 categories into Sri Lanka totaling $450.0K.

National Programme FOR TB — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The National Programme for Tuberculosis Control and Chest Diseases (NPTCCD) is the central organization under Sri Lanka's Ministry of Health, dedicated to controlling and preventing tuberculosis (TB) and other respiratory diseases nationwide. Established in 2001, NPTCCD coordinates and monitors TB and chest disease control activities, aiming to create a TB-free Sri Lanka. (nptccd.health.gov.lk)

As a government entity, NPTCCD is not a pharmaceutical buyer or importer. Instead, it focuses on policy formulation, planning, coordination, and monitoring of TB and chest disease control activities across the country. The organization operates through district chest clinics covering all 26 districts, providing free diagnostic and treatment services to TB patients. (nptccd.health.gov.lk)

2Distribution Network

NPTCCD's distribution network comprises district chest clinics located throughout Sri Lanka, ensuring nationwide coverage for TB control and prevention. These clinics are strategically positioned to provide accessible diagnostic and treatment services to the population. The organization collaborates with various stakeholders, including the World Health Organization and the Global Fund, to strengthen its logistics capabilities and enhance service delivery. (nptccd.health.gov.lk)

3Industry Role

NPTCCD plays a pivotal role in Sri Lanka's pharmaceutical supply chain by acting as a central coordinator for TB control and prevention efforts. While it does not function as a pharmaceutical buyer or importer, it is responsible for the procurement and distribution of TB medications through its network of district chest clinics. The organization ensures that TB patients have access to effective diagnosis, treatment, and rehabilitation services, thereby contributing significantly to public health. (nptccd.health.gov.lk)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — National Programme FOR TB

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

NPTCCD's procurement strategy for TB medications involves sourcing from a limited number of suppliers to maintain consistency and quality. The organization has engaged with a single supplier, MACLEODS PHARMACEUTICALS LIMITED, for its TB medication needs. This single-source dependency may present risks related to supply chain disruptions or changes in supplier terms. However, the consistent sourcing from one supplier suggests a strategic choice to ensure uniformity in product quality and availability. The five shipments from MACLEODS PHARMACEUTICALS LIMITED indicate a stable and ongoing relationship, which is crucial for maintaining uninterrupted supply and quality control.

2Supply Chain Resilience

NPTCCD's supply chain resilience is closely tied to its relationship with MACLEODS PHARMACEUTICALS LIMITED. The organization's reliance on a single supplier for TB medications could pose challenges in the event of supply chain disruptions, such as production delays or logistical issues. Diversifying suppliers and formulations could enhance resilience by mitigating risks associated with single-source dependency. Additionally, ensuring that suppliers comply with international Good Manufacturing Practice (GMP) standards is essential for maintaining the quality and safety of TB medications.

Strategic Implications

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

The National Medicines Regulatory Authority (NMRA) is the primary regulatory body overseeing pharmaceutical imports in Sri Lanka. Established in 2015, NMRA operates under the Ministry of Health and is responsible for ensuring the safety, efficacy, and quality of medicinal products, medical devices, and borderline products. The NMRA enforces regulations that govern the importation, registration, and distribution of pharmaceutical products, aiming to protect public health by maintaining stringent standards throughout the pharmaceutical supply chain.

Key legislation governing pharmaceutical imports includes the Medicines (Pricing Mechanism for Medicines) Regulations, which establish a standardized pricing formula for imported medicines. This formula considers the Cost, Insurance, and Freight (CIF) value, the Supply Chain Total Markup (SCTM), and applicable duties and taxes to determine the Maximum Retail Price (MRP) of medicines. The NMRA reviews and revises the MRP during new registration, re-registration, renewal, or when issuing a new import license, ensuring that prices remain competitive and sustainable.

2Import Licensing & GMP

Import licensing requirements in Sri Lanka mandate that all pharmaceutical products be registered with the NMRA before importation. Import license applications should be submitted at least twelve weeks in advance to avoid delays. As of February 2026, the NMRA has introduced new requirements for price submissions, particularly for import licenses that expire on or after 1st February 2026. Importers must provide price details through a specified format, along with evidence of importation during the past two years or proof of participation in tenders.

National Programme FOR TB — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

NPTCCD's product strategy focuses on the procurement of TB medications, including Rifampicin, Isoniazid, and Ethambutol, which are essential for the treatment of tuberculosis. The organization imports these medications to ensure that TB patients have access to effective treatment regimens. The market demand for these products is driven by the need to control and prevent TB, a significant public health concern in Sri Lanka. By focusing on these specific therapeutic areas, NPTCCD aims to reduce the incidence and mortality rates associated with TB. (nptccd.health.gov.lk)

2Sourcing Profile

NPTCCD's sourcing strategy for TB medications involves importing finished pharmaceutical formulations from a single supplier, MACLEODS PHARMACEUTICALS LIMITED. This approach ensures consistency in product quality and availability. The organization imports five unique formulations, including Rifampicin, Isoniazid, and Ethambutol, to provide comprehensive treatment options for TB patients. By sourcing from India, NPTCCD leverages the country's established pharmaceutical manufacturing capabilities and cost-effectiveness.

3Market Positioning

Seller's Guide — How to Become a Supplier to National Programme FOR TB

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a potential opportunity for new Indian suppliers to engage with NPTCCD, especially if they can offer competitive pricing, ensure compliance with international quality standards, and demonstrate reliability in supply chain management. However, NPTCCD's current sourcing pattern, characterized by a single-source dependency, suggests that any new supplier would need to meet stringent criteria to be considered. Additionally, the organization's focus on maintaining consistent product quality and availability may limit the scope for introducing new suppliers without substantial evidence of their capabilities.

2Requirements & Qualifications

Indian exporters seeking to supply NPTCCD must ensure that their products are registered with the NMRA and comply with Sri Lankan import

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — National Programme FOR TB

What products does National Programme FOR TB import from India?

National Programme FOR TB imports 3 pharmaceutical products across 2 categories. Top imports: Rifampicin ($200.0K), Isoniazid ($150.0K), Ethambutol ($100.0K).

Who supplies pharmaceuticals to National Programme FOR TB from India?

National Programme FOR TB sources from 1 verified Indian suppliers. The primary supplier is Macleods Pharmaceuticals Limited (100.0% of imports, $250.0K).

What is National Programme FOR TB's total pharmaceutical import value?

National Programme FOR TB's total pharmaceutical import value from India is $450.0K, based on 9 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does National Programme FOR TB focus on?

National Programme FOR TB imports across 2 categories. The largest: Tuberculosis Medications (55.6%), Advanced Antibiotics (44.4%).

Get Full National Programme FOR TB Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.